Alibaba Health stock stood at HKD 3.00 on October 16, 2026, at 21.39 times earnings
Published on 10/17/2026 at 19:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSValuation and trading position
- Alibaba Health traded at 21.39 times earnings on October 16, 2026.
- The company had a HKD 48.6 billion market value on October 16, 2026.
- Alibaba Health stock last traded at HKD 3.00 at 4:08 p.m. HKT on October 16, 2026, up 1.52 percent on Hong Kong Stock Exchange.
- Trading volume reached 81,468,067 shares against an average of 73,624,012 shares.
Alibaba Health stock stood at HKD 3.00 on October 16, 2026, at 21.39 times earnings. The market value was HKD 48.6 billion, giving investors a dated view of the company after the Hong Kong session had ended. The share price was up 1.52 percent on the day, based on the Hong Kong Stock Exchange quotation.
Valuation at 21.39 times earnings
The valuation measure was accompanied by a trailing dividend yield of 0.07 percent on October 16, 2026. Alibaba Health operates in healthcare information services, with pharmaceutical direct sales, an online pharmacy platform and digital healthcare services forming its main business lines.
The company also serves customers through online channels and offline pharmacy outlets. Its business mix gives the valuation a direct connection to prescription drugs, consumer health products and healthcare-related digital services rather than to a single product category.
Range leaves room below the high
The 52-week range was HKD 2.75 to HKD 7.91 on October 16, 2026. The latest price therefore sat within that range and was HKD 0.25 above the yearly low. Trading volume reached 81,468,067 shares, compared with an average of 73,624,012 shares.
The dated market picture is therefore defined by three numbers: HKD 3.00 for the last price, 21.39 times earnings for valuation and HKD 48.6 billion for market value. The 0.07 percent dividend yield remains a separate income measure rather than a price movement signal.
Comparison with peers
Alibaba Health: plus 1.52 percent, 21.39 times earnings, market capitalization HKD 48.6 billion.
CSPC Pharmaceutical Group (Hong Kong Stock Exchange, HKD): plus 0.17 percent, 11.62 times earnings, market capitalization HKD 101.3 billion.
GF Securities (Hong Kong Stock Exchange, HKD): unchanged, 8.31 times earnings, market capitalization HKD 169.7 billion.
Trading position on October 16
Alibaba Health ended the completed Hong Kong session with a higher daily quotation and a price below its 52-week high of HKD 7.91. The next market perspective is the relationship between the current valuation, the 52-week range and the company market value.
The last available quotation was HKD 3.00 on Hong Kong Stock Exchange on October 16, 2026 at 4:08 p.m. HKT, up 1.52 percent on the day.
Alibaba Health market data
- Company: Alibaba Health Information Technology Limited
- ISIN: BMG0171K1018
- Ticker: 0241.HK
- Primary exchange: Hong Kong Stock Exchange
- Last price Hong Kong Stock Exchange: HKD 3.00 (as of October 16, 2026, 4:08 p.m. HKT)
- Change on Hong Kong Stock Exchange: plus 1.52 percent on October 16, 2026
- Market capitalization: HKD 48.6 billion (as of October 16, 2026)
- 52-week range: HKD 2.75-HKD 7.91 (as of October 16, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Information Services
- Price-earnings ratio: 21.39 (as of October 16, 2026)
- Dividend yield: 0.07 percent (as of October 16, 2026)
Market context: Latest market reports.
